MedXY
Not signed in Sign in / Register
Skip to content
medxy logo Medxy AI
  • Specialties
    • Allergy & Immunology
    • Anesthesiology
    • Cardiology
    • Critical Care
    • Dermatology
    • Diabetes & Endocrinology
    • Emergency Medicine
    • Family Medicine & Nutrition
    • Gastroenterology
    • General Surgery
    • Hematology-Oncology
    • HIV/AIDS
    • Infectious Diseases
    • Internal Medicine
    • Nephrology
    • Neurology
    • Nursing & care
    • OB/GYN & Women’s Health
    • Oncology
    • Ophthalmology
    • Orthopedics
    • Otorhinolaryngology
    • Pathology & Lab Medicine
    • Pediatrics
    • Plastic Surgery
    • Psychiatry
    • Public Health
    • Radiology
    • Respiratory
    • Rheumatology
    • Urology
  • iDoctor
  • Medical Calculators
  • Videos
  • Health Games
  • Specialties
    • Allergy & Immunology
    • Anesthesiology
    • Cardiology
    • Critical Care
    • Dermatology
    • Diabetes & Endocrinology
    • Emergency Medicine
    • Family Medicine & Nutrition
    • Gastroenterology
    • General Surgery
    • Hematology-Oncology
    • HIV/AIDS
    • Infectious Diseases
    • Internal Medicine
    • Nephrology
    • Neurology
    • Nursing & care
    • OB/GYN & Women’s Health
    • Oncology
    • Ophthalmology
    • Orthopedics
    • Otorhinolaryngology
    • Pathology & Lab Medicine
    • Pediatrics
    • Plastic Surgery
    • Psychiatry
    • Public Health
    • Radiology
    • Respiratory
    • Rheumatology
    • Urology
  • iDoctor
  • Medical Calculators
  • Videos
  • Health Games

Aesthetic dermatology

Search medical newsFind research, conditions and clinical updates
  • Home
  • Aesthetic dermatology
液体 RelabotulinumtoxinA 治疗眉间纹的长期美容疗效与安全性:一项12个月随机对照试验
Posted inClinical Updates Dermatology Plastic Surgery

Long-Term Aesthetic Efficacy and Safety of Liquid RelabotulinumtoxinA for Glabellar Lines: A 12-Month Randomized Controlled Trial

Posted by By MedXY 11/20/2026
A phase 3b randomized trial demonstrates that liquid RelabotulinumtoxinA offers rapid, durable aesthetic improvement of glabellar lines with high patient and injector satisfaction and a favorable safety profile over 12 months.
Read More

Take a game break

Explore a few games from MedXY.

Explore all games
  • AI-Assisted Riemann Hypothesis Claim Sparks Debate Over Verification—and Signals a Broader “AI Moment” for Science
  • 1.5 kg Emerges as a Key Risk Threshold in Transcatheter PDA Closure for Small Infants
  • Harnessing Digital Parenting to Reduce Childhood Sexual Violence and Maltreatment: Evidence from a Large-scale Tanzanian Trial
  • Integrating Children into the Primary Care Investment Conversation: A Critical Imperative
  • Targeting FcRn to Combat Systemic Sclerosis: Promising Preclinical Advances with Efgartigimod
  • About us
  • Contact us
  • MedXY story
  • Privacy Policy
  • Subscribe Now!

  • English
  • 日本語
  • Tiếng Việt
  • 中文

Alzheimer's disease artificial intelligence atrial fibrillation biomarkers breast cancer Cardiology cardiovascular disease cardiovascular risk case report chronic kidney disease clinical trial clinical trials critical care diabetes epidemiology GLP-1 receptor agonists heart failure hepatocellular carcinoma Hypertension immunotherapy inflammation machine learning MASLD mental health Mortality multiple myeloma myocardial infarction nutrition obesity older adults oncology Pediatrics precision medicine Pregnancy prognosis public health quality of life randomized clinical trial randomized controlled trial risk stratification SGLT2 inhibitors stroke targeted therapy type 1 diabetes type 2 diabetes

Your health, we care

Copyright 2026 — Medxy AI. All rights reserved.
Scroll to Top